Vote Scores
Filings read through

Rhythm Pharmaceuticals, Inc.: how funds voted at the meeting of 18 Sep 2024

Ticker
RYTM
Meeting
Season
year to 30 June 2025
Filers reporting
313
Ballot items
4

313 filers on Form N-PX reported votes at the Rhythm Pharmaceuticals, Inc. meeting of 18 Sep 2024. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Rhythm Pharmaceuticals, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    3 nominees. 61.2% of the reported votes are for. 53 filers withheld from or voted against at least one nominee.

    561 vote records from 116 filers. 41 of the 116 filers that marked the item voted against management.

    • Positions of 37 fund families
    • For 25
    • Abstain or withhold 12
    • Against management 12
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    423 vote records from 311 filers. 24 of the 303 filers that marked the item voted against management. 8 filers gave no management mark.

    • Positions of 41 fund families
    • For 40
    • Against 1
    • Against management 1
  3. Item 3: Audit-related items (auditor ratification)

    187 vote records from 116 filers. 1 of the 116 filers that marked the item voted against management.

    • Positions of 37 fund families
    • For 37
  4. Item 4: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    190 vote records from 118 filers. 99 of the 118 filers that marked the item voted against management.

    • Positions of 37 fund families
    • For 5
    • Against 32
    • Against management 32

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Rhythm Pharmaceuticals, Inc., meeting of 18 Sep 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinForNo report
Artisan PartnersForFor
BlackRock and iSharesForFor
BNY MellonForFor
Brighthouse FundsForFor
Charles SchwabForFor
Columbia ThreadneedleForNo report
DimensionalForNo report
DWSForFor
EquitableForFor
Federated HermesForFor
FidelityForFor
First TrustForFor
Franklin TempletonForFor
Global XForFor
Goldman SachsForFor
Guggenheim and RydexForFor
Harbor FundsForFor
InvescoAgainst, against managementFor
J.P. MorganForFor
Janus HendersonForFor
John Hancock and ManulifeForFor
Lincoln FinancialForFor
Lord AbbettForFor
Morgan Stanley, Eaton Vance and CalvertForFor
NationwideForFor
Natixis and Loomis SaylesForFor
Neuberger BermanForNo report
Northern Trust and FlexSharesForFor
Nuveen and TIAAForFor
Pacific Life fundsForFor
PGIM and PrudentialForFor
PrincipalForFor
ProShares and ProFundsForFor
SEIForFor
State Street and SPDRForFor
T. Rowe PriceForFor
TransamericaForFor
VanguardForFor
Victory CapitalForFor
VoyaForFor

Questions

How many filers reported votes at the Rhythm Pharmaceuticals, Inc. meeting?
313 Form N-PX filers reported votes at the meeting of 18 Sep 2024. On say-on-pay, 24 of 303 filers that marked the item voted against management (7.9%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Rhythm Pharmaceuticals, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Rhythm Pharmaceuticals, Inc. with a meeting date within three days of 18 Sep 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .